INCOME TAXES	9 Months Ended
Mar. 28, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The income tax benefit of $0.5 million and income tax provision of $0.4 million for the three and nine months ended March 28, 2015, respectively, and the income tax provision of $0.7 million and $2.5 million for the three and nine months ended March 29, 2014, respectively, relates primarily to our foreign operations. The total amount of our unrecognized tax benefits as of March 28, 2015 and June 28, 2014 were approximately $3.6 million and $4.2 million, respectively. As of March 28, 2015, we had $3.0 million of unrecognized tax benefits that, if recognized, would affect our effective tax rate. While it is often difficult to predict the final outcome of any particular uncertain tax position, we believe that unrecognized tax benefits could decrease by approximately $1.0 million in the next twelve months. On December 19, 2014, the President of the U.S. signed into law The Tax Increase Prevention Act of 2014, which retroactively extends more than 50 expired tax provisions through 2014. Among the extended provisions is the Sec. 41 research credit for qualified research expenditures incurred through the end of 2014. The benefit of the reinstated credit did not impact the condensed consolidated statement of operations in the period of enactment, which was the second quarter of fiscal year 2015, as the research and development credit carryforwards are offset by a full valuation allowance.

INCOME TAXES

9 Months Ended

Mar. 28, 2015

The income tax benefit of $0.5 million and income tax provision of $0.4 million for the three and nine months ended March 28, 2015, respectively, and the income tax provision of $0.7 million and $2.5 million for the three and nine months ended March 29, 2014, respectively, relates primarily to our foreign operations.

The total amount of our unrecognized tax benefits as of March 28, 2015 and June 28, 2014 were approximately $3.6 million and $4.2 million, respectively. As of March 28, 2015, we had $3.0 million of unrecognized tax benefits that, if recognized, would affect our effective tax rate. While it is often difficult to predict the final outcome of any particular uncertain tax position, we believe that unrecognized tax benefits could decrease by approximately $1.0 million in the next twelve months.

On December 19, 2014, the President of the U.S. signed into law The Tax Increase Prevention Act of 2014, which retroactively extends more than 50 expired tax provisions through 2014. Among the extended provisions is the Sec. 41 research credit for qualified research expenditures incurred through the end of 2014. The benefit of the reinstated credit did not impact the condensed consolidated statement of operations in the period of enactment, which was the second quarter of fiscal year 2015, as the research and development credit carryforwards are offset by a full valuation allowance.